BioHealth News Archive
Governor Hogan Introduces Safe, Gradual, and Effective ‘Maryland Strong: Roadmap to Recovery’
ANNAPOLIS, MD—After weeks of consulting with leading scientists, business leaders, and public health experts, Governor Larry Hogan today introduced the ‘Maryland Strong: Roadmap to Recovery,’ which…
Read MoreFive takeaways from Gov. Larry Hogan’s plan to reopen Maryland – Baltimore Sun
Maryland Gov. Larry Hogan on Friday announced his three-phase plan to eventually reopen the state amid the coronavirus pandemic. Hogan called the plan a…
Read More
This physician-founder is making a device to protect medical staff during intubation procedures – Technical.ly Baltimore
Working as an emergency and critical care physician at the University of Maryland School of Medicine, Dr. Steven Tropello is seeing the lack of…
Read More
Emergex Signs Agreement with GEORGE MASON UNIVERSITY for Highly Pathogenic RNA Virus Studies
Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered…
Read More
Baltimore Company Will Produce COVID-19 Vaccine Under New Agreement With Johnson & Johnson | WBFF
A Baltimore company will be at the forefront of producing a potential coronavirus vaccine. Once a COVID-19 vaccine is ready for mass production, the…
Read More
AGT CEO Jeff Galvin on the Future of the Gene and Cell Therapy Industry | BioSpace
The rapid growth of biopharma is causing a shift to a new paradigm for the drug development and delivery model. In the same manner…
Read More
Colleges make plans for bringing students back 2020 – The Washington Post
In a different year, incoming freshmen would already have in hand a tightly choreographed schedule for late summer and early fall: the move-in date,…
Read More
Dr. Anthony Fauci ‘Not Overly Confident’ With US COVID-19 Testing | TIME
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and member of the White House Coronavirus Task Force, says “we…
Read More
J&J to partner with Emergent Bio on coronavirus vaccine candidate (NYSE:JNJ) | Seeking Alpha
Johnson & Johnson (NYSE:JNJ) says it will work with Emergent BioSolutions (NYSE:EBS) to produce more than a billion doses of a COVID-19 vaccine candidate,…
Read More
Performance of calprotectin and cystatin C in prediction of severe events in COVID-19 patients
We at Gentian AS believe it is the duty of all companies in the health industry to help combat the ongoing pandemic of COVID-19/Corona…
Read More
Immunomic Therapeutics Announces Close of $61.3M Financing – Bloomberg
Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today the close of a $61.3M…
Read More
5 trends in venture capital (beyond the pandemic) | MIT Sloan
Even prior to COVID-19, change was afoot in the venture capital industry. Machine learning and algorithms were emerging as new ways to spot winners,…
Read More
How to reopen the US, according to Johns Hopkins and Harvard – Business Insider
Most Americans are still stuck at home, but a trio of reports, out from Harvard, Johns Hopkins, and former US Food and Drug Administration…
Read More
What Is Contact Tracing? How It Will Be Used for COVID-19 | Time
In the coronavirus era, a host of epidemiological terms have entered common public use. There’s the now-ubiquitous “social distancing,” and the newly politicized “flatten…
Read More
Xconomy: Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle
Even as the novel coronavirus has derailed daily life and business operations, the life sciences sector continues to see companies make public debuts and…
Read More